Technology | November 20, 2017

Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography

Five-megapixel monitor displays both monochrome and color images in high detail

Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography

November 20, 2017 — Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis and digital mammography for its 5-megapixel color medical monitor, the RadiForce RX560.

Watch the VIDEO Eizo Introduces the RadiForce RX560 at RSNA 2017.

Breast cancer screenings increasingly combine the use of mammography and ultrasound to view patients with high breast density. Furthermore, if breast cancer is suspected, various other tests may also be needed such as biopsy, breast magnetic resonance imaging (MRI) and computed tomography (CT). Because of this, monitors that can accurately display tomosynthesis, mammography and general radiology are becoming increasingly important.

The RX560 is the world's first medical monitor to use a low temperature polysilicon (LTPS) liquid crystal display, according to Eizo. Because of this, the color monitor can reach a brightness of up to 1100 cd/m2, similar to that of monochrome monitors. In order to detect the smallest structures within breast tissue, the monitor offers a high contrast ratio of 1,500:1. Furthermore the monitor has a response time of 12 milliseconds, making it ideal for enlarging and panning medical images, as well as quickly displaying 3-D breast tomosynthesis which is comprised of several images in each shot. The 5 megapixel (2,048 x 2,560) resolution is ideal for viewing the fine details in breast images.

The RX560 is able to display both monochrome and color medical images on the same screen due to the Hybrid Gamma PXL function included with the monitor. With this function, both monochrome and color images are set to the optimum grayscale and gamma curve pixel-by-pixel, improving the efficiency of interpretation work.  

Eizo will demonstrate the RadiForce RX560 at the 103rd Radiological Society of North America Annual Meeting (RSNA 2017), Nov. 26-Dec. 1 in Chicago.

For more information: www.eizo.com

Related Content

iCAD's ProFound AI Wins Best New Radiology Solution in 2019 MedTech Breakthrough Awards
News | Computer-Aided Detection Software | September 09, 2019
iCAD Inc. announced MedTech Breakthrough, an independent organization that recognizes the top companies and solutions...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used deep learning, a form of machine learning, which is a type of artificial intelligence. Image courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Society of Breast Imaging (SBI) | September 06, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
Ashley County Medical Center Installs Arkansas' First Fujifilm Aspire Cristalle With DBT
News | Mammography | August 27, 2019
Fujifilm Medical Systems U.S.A. Inc. recently announced that Ashley County Medical Center (Crossett, Ark.) has invested...
FDA Encourages Inclusion of Male Patients in Breast Cancer Clinical Trials
News | Women's Health | August 26, 2019
The U.S. Food and Drug Administration (FDA) released a new draft guidance that encourages including male patients in...
Moffitt Researchers Develop Model to Personalize Breast Cancer Radiation Treatment
News | Radiation Therapy | August 26, 2019
A personalized approach to cancer treatment has become more common over the last several decades, with numerous...
Sectra Signs Enterprise Imaging Contract With Vanderbilt Health
News | Enterprise Imaging | August 21, 2019
Sectra will install its enterprise imaging picture archiving and communication system (PACS) and vendor neutral archive...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
Lunit Receives Korea MFDS Approval for Lunit Insight MMG
News | Artificial Intelligence | August 19, 2019
Lunit has announced Korea Ministry of Food and Drug Safety (MFDS) approval of its artificial intelligence (AI) solution...
Imago Systems Announces Collaboration With Mayo Clinic for Breast Imaging

Image courtesy of Imago Systems

News | Mammography | August 14, 2019
Image visualization company Imago Systems announced it has signed a know-how license with Mayo Clinic. The multi-year...
Artificial Intelligence Could Yield More Accurate Breast Cancer Diagnoses
News | Artificial Intelligence | August 13, 2019
University of California Los Angeles (UCLA) researchers have developed an artificial intelligence (AI) system that...